Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

829 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
Dorian P, Langer A, Morgan C, Casella L, Harris L, Armstrong P. Dorian P, et al. Am J Cardiol. 1994 Sep 1;74(5):419-23. doi: 10.1016/0002-9149(94)90895-8. Am J Cardiol. 1994. PMID: 7520209 Clinical Trial.
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial.
Klootwijk P, Langer A, Meij S, Green C, Veldkamp RF, Ross AM, Armstrong PW, Simoons ML. Klootwijk P, et al. Eur Heart J. 1996 May;17(5):689-98. doi: 10.1093/oxfordjournals.eurheartj.a014935. Eur Heart J. 1996. PMID: 8737099 Clinical Trial.
Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers.
Armstrong PW, Mant MJ. Armstrong PW, et al. Eur Heart J. 1995 Nov;16 Suppl L:75-80. doi: 10.1093/eurheartj/16.suppl_l.75. Eur Heart J. 1995. PMID: 8869023 Review.
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries.
Tsang TS, Califf RM, Stebbins AL, Lee KL, Cho S, Ross AM, Armstrong PW. Tsang TS, et al. Am J Cardiol. 1997 May 1;79(9):1232-5. doi: 10.1016/s0002-9149(97)00087-8. Am J Cardiol. 1997. PMID: 9164891 Clinical Trial.
Spectrum of ischemic heart disease and the role of biochemical markers.
Tymchak WJ, Armstrong PW. Tymchak WJ, et al. Clin Lab Med. 1997 Dec;17(4):701-25. Clin Lab Med. 1997. PMID: 9439880 Review.
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW. Goodman SG, et al. Circulation. 1998 Feb 10;97(5):444-50. doi: 10.1161/01.cir.97.5.444. Circulation. 1998. PMID: 9490238 Clinical Trial.
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion.
Kleiman NS, Granger CB, White HD, Armstrong P, Ardissino D, de Werf FV, Zoldeyhi P, Thompson TD, Califf RM, Topol EJ. Kleiman NS, et al. Am Heart J. 1999 Jan;137(1):12-23. doi: 10.1016/s0002-8703(99)70455-2. Am Heart J. 1999. PMID: 9878932 Clinical Trial.
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
Hasdai D, Holmes DR Jr, Topol EJ, Berger PB, Criger DA, Hochman JS, Bates ER, Vahanian A, Armstrong PW, Wilcox R, Ohman EM, Califf RM. Hasdai D, et al. Eur Heart J. 1999 Jan;20(2):128-35. doi: 10.1053/euhj.1999.1282. Eur Heart J. 1999. PMID: 10099909 Clinical Trial.
829 results
Jump to page